OncBioMune Pharmaceuticals, Inc Business Finance Contracts & Agreements

146 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Theralink Technologies, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2024
Amended and Restated Security Agreement among Theralink Technologies, Inc., Secured Parties, and Cavalry Fund I Management LLC (Agent)
Security Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2023
Theralink Technologies, Inc. 2023 Convertible Secured Promissory Note with IMAC Holdings, Inc.
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2023
Security Agreement among Theralink Technologies, Inc., Secured Parties, and Cavalry Fund I Management LLC (November 29, 2022)
Security Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2022
Securities Purchase Agreement between Theralink Technologies, Inc. and Purchasers (November 29, 2022)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Placement Agency Agreement between Theralink Technologies, Inc. and Joseph Gunnar & Co., LLC (November 29, 2022)
Equity Distribution Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2022
Theralink Technologies, Inc. 10.0% Original Issue Discount Senior Secured Convertible Debenture Due November 29, 2023
Debenture Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Common Stock Purchase Warrant Agreement between Theralink Technologies, Inc. and Holder
Warrant Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2022
Theralink Technologies, Inc. 10.0% Original Issue Discount Senior Secured Convertible Debenture Due 2023
Debenture Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Demand Promissory Note between Theralink Technologies, Inc. and Lender
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
CO
2022
Securities Purchase Agreement between Theralink Technologies, Inc. and Investors (April 2022)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Common Stock Purchase Warrant Agreement between Theralink Technologies, Inc. and Holder (April 2022)
Warrant Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Theralink Technologies, Inc. 2022 Convertible Promissory Note Agreement
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Securities Purchase Agreement between Theralink Technologies, Inc. and Investors (January 2022)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Common Stock Purchase Warrant Agreement between Theralink Technologies, Inc. and Holder (January 2022)
Warrant Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Securities Purchase Agreement between Theralink Technologies, Inc. and Investors (November 1, 2021)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Common Stock Purchase Warrant Agreement between Theralink Technologies, Inc. and Holder (November 2021)
Warrant Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Theralink Technologies, Inc. 2021 Convertible Promissory Note Agreement with Holder
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Securities Purchase Agreement between Theralink Technologies, Inc. and Investors (Series F Convertible Preferred Stock and Warrants)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Common Stock Purchase Warrant Agreement between Theralink Technologies, Inc. and Doug Mergenthaler (July 30, 2021)
Warrant Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Security Agreement between Theralink Technologies, Inc. and Ashton Capital Corporation (May 12, 2021)
Security Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
CO
2021
Securities Purchase Agreement between Theralink Technologies, Inc. and Investors (May 12, 2021)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Common Stock Purchase Warrant Agreement between Theralink Technologies, Inc. and Ashton Capital Corporation (May 12, 2021)
Warrant Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Theralink Technologies, Inc. 2021 Convertible Secured Promissory Note with Ashton Capital Corporation
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2021
Registration Rights Agreement between Theralink Technologies, Inc. and Shareholders (March 2021)
Registration Rights Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
CO
2021
Theralink Technologies, Inc. Subscription Agreement for Private Placement of Common Stock
Subscription Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
CO
2021
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Doug Mergenthaler dated September 16, 2020
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2020
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Investors for Series C-2 Convertible Preferred Stock
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2020
Exchange Agreement between OncBioMune Pharmaceuticals, Inc. and Jonathan F. Head, Ph.D. for Series D-2 Convertible Preferred Stock
Exchange Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2020
Exchange Agreement between OncBioMune Pharmaceuticals, Inc. and Investors for Series C-2 Convertible Preferred Stock
Exchange Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2020
Exchange Agreement between OncBioMune Pharmaceuticals, Inc. and Investors for Series C-1 Convertible Preferred Stock
Exchange Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2020
Common Stock Purchase Warrant Agreement between OncBioMune Pharmaceuticals, Inc. and Doug Mergenthaler (June 5, 2020)
Warrant Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2020
Common Stock Purchase Warrant Agreement between OncBioMune Pharmaceuticals, Inc. and Holder (June 2020)
Warrant Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2020
Asset Purchase Agreement between Avant Diagnostics, Inc. and Oncbiomune Pharmaceuticals, Inc. dated May 12, 2020
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2020
Description of OncBioMune Pharmaceuticals, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2020
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and JEB Partners, L.P. dated September 25, 2019
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Common Stock Purchase Warrant Agreement between OncBioMune Pharmaceuticals, Inc. and JEB Partners, L.P.
Warrant Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2019
OncBioMune Pharmaceuticals, Inc. 10% Senior Convertible Note Due May 25, 2020 (JEB Partners, L.P.)
Note Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Securities Purchase Agreement between OncBioMune Pharmaceuticals, Inc. and Purchasers (June 3, 2019)
Purchase Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2019
Common Stock Purchase Warrant Agreement between OncBioMune Pharmaceuticals, Inc. and Holder (June 3, 2019)
Warrant Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
2019